Acetaminophen 250 mg and Ibuprofen 125 mg
- Product NDC
- 43598-052
- Requested package NDC
- 43598-052-95
- 11-digit product format
- 435980052
- Labeler code
- 43598
- Product ID
- 43598-052_49a54544-f18b-6461-9ed0-2740e8df4b6c
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen and Ibuprofen
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Dr. Reddy's Labortories Inc
- Application
- ANDA218247
- Marketing category
- ANDA
- Marketing start
- 2025-02-19
- Substance
- IBUPROFEN; ACETAMINOPHEN
- Active strength
- 125; 250 mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A218247-001 | ACETAMINOPHEN AND IBUPROFEN | ACETAMINOPHEN; IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2024-08-23 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A218247-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2024-08-23 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A218247-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2024-08-23 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A218247-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2024-08-23 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A218247-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2024-08-23 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A218247-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2024-08-23 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A218247-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2024-08-23 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A218247-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2024-08-23 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A218247-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2024-08-23 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A218247-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2024-08-23 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A218247-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2024-08-23 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A218247-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2024-08-23 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A218247-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2024-08-23 | d06236e962d9… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A218247-001 | ACETAMINOPHEN AND IBUPROFEN | 250MG;125MG | TABLET / ORAL | 2024-08-23 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Acetaminophen 250 mg and Ibuprofen 125 mg
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| IBUPROFEN | 125 mg/1 |
| ACETAMINOPHEN | 250 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| WK2XYI10QM | Internal UNII lookup |
| 362O9ITL9D | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2387532 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3e65c8a3-498e-1a2a-bb76-18e28ae2c73c | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43598-052-05 | Acetaminophen 250 mg and Ibuprofen 125 mg | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 6 | |
| 43598-052-14 | Acetaminophen 250 mg and Ibuprofen 125 mg | 144 in 1 BOTTLE | TABLET, FILM COATED | 144 | 6 | |
| 43598-052-18 | Acetaminophen 250 mg and Ibuprofen 125 mg | 18 in 1 BOTTLE | TABLET, FILM COATED | 18 | 6 | |
| 43598-052-18 | Acetaminophen 250 mg and Ibuprofen 125 mg | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 6 | |
| 43598-052-25 | Acetaminophen 250 mg and Ibuprofen 125 mg | 250 in 1 BOTTLE | TABLET, FILM COATED | 250 | 6 | |
| 43598-052-25 | Acetaminophen 250 mg and Ibuprofen 125 mg | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 6 | |
| 43598-052-95 | Acetaminophen 250 mg and Ibuprofen 125 mg | 250 in 1 BOTTLE | TABLET, FILM COATED | 250 | 6 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dual Action | ACETAMINOPHEN AND IBUPROFEN (NSAID) TABLETS, 250 MG/ 125 MG | Dr. Reddy's Laboratories Inc | c8a8a18a-6766-37a9-d0f0-f9380fb5b0e8 | 2025-07-18 | Warnings | 218247 ANDA218247 |
| Acetaminophen 250 mg and Ibuprofen 125 mg | ACETAMINOPHEN AND IBUPROFEN | Dr. Reddy's Labortories Inc | 3e65c8a3-498e-1a2a-bb76-18e28ae2c73c | 2025-04-04 | Warnings | 218247 ANDA218247 43598-052-95 43598-052 43598005295 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2387532 | acetaminophen 250 MG / ibuprofen 125 MG Oral Tablet | PSN | 3e65c8a3-498e-1a2a-bb76-18e28ae2c73c | 6 |
| 2387532 | acetaminophen 250 MG / ibuprofen 125 MG Oral Tablet | SCD | 3e65c8a3-498e-1a2a-bb76-18e28ae2c73c | 6 |
| 2387532 | APAP 250 MG / ibuprofen 125 MG Oral Tablet | SY | 3e65c8a3-498e-1a2a-bb76-18e28ae2c73c | 6 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 43598-052-95 | 43598005295 | 250 TABLET, FILM COATED in 1 BOTTLE (43598-052-95) | 2025-02-19 | No | No | Current |